Valens Semiconductor Ltd. filings document the company’s foreign-issuer current reports, semiconductor connectivity business, governance matters and capital-structure disclosures. Form 6-K reports furnish earnings releases, product announcements involving VA7000 A-PHY chipsets and automotive camera applications, annual meeting voting results, management-transition disclosure, and exhibits incorporated by reference into Form F-3 and Form S-8 registration statements.
The filing record also covers operating and financial results, material-event disclosures, risk factors and corporate governance under the company’s public-company reporting framework. These documents relate to Valens’ audio-video and automotive connectivity markets, including high-speed video and data transmission technologies tied to HDBaseT and MIPI A-PHY.
This Form 144 notice states that holder Dror Jerushalmi intends to sell 20,000 ordinary shares of issuer VLN through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $46,200.00. The issuer has 106,342,415 ordinary shares outstanding.
The 20,000 shares to be sold were acquired on 06/01/2017 under an Employee Stock Option Plan from the issuer and are to be paid for in cash upon exercise on 01/12/2026.
Over the past three months, the same seller reported multiple sales of ordinary shares, including 24,000 shares on 12/05/2025 for $40,800.00 and 139,431 shares on 01/09/2026 for $249,791.27. By signing, the seller represents that they are not aware of undisclosed material adverse information about the issuer’s operations.
A shareholder of VLN has filed a Rule 144 notice to sell 139,431 ordinary shares through Oppenheimer & Co. Inc. on the NYSE, with an approximate sale date of 01/09/2026 and an indicated aggregate market value of 217,512.36. The filing notes that 106,342,415 ordinary shares of the issuer are outstanding.
The shares to be sold were acquired on 06/01/2017 under an Employee Stock Option Plan from the issuer, with the purchase price to be paid in cash upon exercise dated 01/09/2026. The notice also lists prior sales over the past three months by the same seller, including 24,000 shares on 12/05/2025 for gross proceeds of 40,800.00 and 58,900 shares on 01/02/2026 for gross proceeds of 90,906.92.
An affiliate of VLN has filed a notice to sell ordinary shares under Rule 144. The filing covers 20,000 ordinary shares, to be sold through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $37,440.00. These shares were acquired on 06/09/2021 through an employee stock options plan and are scheduled to be paid for in cash upon exercise on 01/09/2026.
The notice also lists recent activity by the same seller, who sold 2,868 ordinary shares on 10/14/2025 for gross proceeds of $5,288.88 and a further 1,132 ordinary shares on 10/15/2025 for gross proceeds of $2,087.52. The issuer had 106,342,415 ordinary shares outstanding at the time referenced, providing context for the size of these planned and recent sales.
VLN has a Form 144 notice for a planned sale of 36,440 ordinary shares, to be executed through Oppenheimer & Co. Inc. on the NYSE around 01/09/2026. The filing lists an aggregate market value of $56,846.40 for these shares and notes that 106,342,415 shares of this class are outstanding.
The shares to be sold were acquired through an employee stock option plan in two grants dated 09/02/2016 (33,127 shares) and 06/01/2017 (3,313 shares), with cash upon exercise scheduled for 01/09/2026. The person filing represents that they are not aware of undisclosed material adverse information about the issuer’s operations.
Valens Semiconductor filed a notice covering a planned sale of ordinary shares under Rule 144. The filing indicates an intention to sell 338,090 ordinary shares through broker Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $527,420.40. These shares are part of a larger base of 106,342,415 shares outstanding. The securities to be sold were acquired on 11/30/2023 via distributions in kind from Genesis Partners III and VALENS S.P.V., meaning they were received as part of a non-cash distribution rather than a direct cash purchase. The approximate sale date listed is 01/09/2026, and the person on whose behalf the sale is planned represents that they are not aware of any undisclosed material adverse information about the company.
VLN received a Form 144 notice for a planned sale of ordinary shares. The shareholder intends to sell 13,000 ordinary shares through Oppenheimer & Co. Inc. on the NYSE around 01/08/2026, in a transaction valued at an aggregate market value of $20,150.00. The filing notes that 106,342,415 ordinary shares were outstanding.
The 13,000 shares to be sold were originally acquired on 06/01/2017 under an Employee Stock Option Plan from the issuer, with payment described as cash upon exercise. The form also lists recent sales over the prior three months by Dror Jerushalmi, including multiple blocks of ordinary shares sold in December 2025 and early January 2026 with disclosed gross proceeds for each sale. The signer represents that they are not aware of undisclosed material adverse information about the issuer.
A shareholder of VLN filed a notice to sell 12,800 ordinary shares through Oppenheimer & Co. Inc. on the NYSE, with an approximate aggregate market value of $19,968.00. The filing lists total ordinary shares outstanding of 106,342,415 and an approximate sale date of 01/05/2026.
The 12,800 shares to be sold were acquired on 06/01/2017 through an employee stock option plan, with payment described as cash upon exercise dated 01/05/2026. Over the prior three months, the same shareholder reported additional ordinary share sales totaling several transactions, including 24,000 shares for $40,800.00 on 12/05/2025 and 58,900 shares for $90,906.92 on 01/02/2026.
A holder of ordinary shares of VLN, identified as Dror Jerushalmi, has filed a notice of proposed sale under Rule 144. The filing covers a planned sale of 58,900 ordinary shares through broker Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $83,638.00 and issuer shares outstanding of 106,342,415. These shares were acquired on 06/01/2017 under an Employee Stock Option Plan from the issuer and will be paid for in cash upon exercise on 01/02/2026. The notice also lists prior sales over the past three months: 24,000, 6,000, and 12,631 ordinary shares on 12/05/2025, 12/08/2025, and 12/09/2025, respectively, with gross proceeds of $40,800.00, $10,200.00, and $21,760.69.